Glimepiride / Pioglitazone Uses, Dosage, Side Effects and Interactions
Duetact
Duetact was the first glimepiride / pioglitazone product the FDA approved, in July 2006. An FDA-approved generic with the same active ingredients is listed.
Glimepiride / Pioglitazone is a two-in-one diabetes tablet (Duetact and generic pioglitazone and glimepiride) that helps lower blood sugar in adults with type 2 diabetes, alongside diet and exercise.
Quick links
Ask Anything About Glimepiride / PioglitazoneType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Glimepiride / Pioglitazone in Short
- Drug classes Sulfonylurea; Peroxisome Proliferator-activated Receptor alpha Agonist; Peroxisome Proliferator-activated Receptor gamma Agonist; Thiazolidinedione How the FDA classifies it
What it treatsGlimepiride / Pioglitazone tablets are used with diet and exercise to improve blood sugar control in adults with type 2 diabetes. Duetact and the generic pioglitazone and glimepiride tablets share this same use. They are meant for people already taking both a thiazolidinedione and a sulfonylurea.
- How you get it Prescription only
- Comes asTablet (by mouth)
- The FDA’s strongest warningBoxed warning The FDA’s most serious alert. Read what it says
- What pharmacies pay
- Generic$9.60 to $9.95 a tablet
- Generic versionYes, FDA-approved Listed with the FDA, which does not mean every pharmacy stocks it
The Pharmacist’s Take
Glimepiride and pioglitazone (Duetact) pairs two older type 2 diabetes medicines in one tablet: pioglitazone, which helps your body use its own insulin better, and glimepiride, which prompts the pancreas to release more insulin. It is usually prescribed for people already taking both, or for people who need a second medicine added, and it has been on the U.S. market since about 2006, with FDA-approved generics listed. Most people tolerate it reasonably well, though weight gain and leg swelling are common and low blood sugar is a real possibility. Its boxed warning is for heart failure, so report fast weight gain, new shortness of breath or swelling promptly, especially after starting or raising the dose.
Key Takeaways From the HelloPharmacist Team
- Take it once a day with your first main meal, and do not skip that meal, since glimepiride can drop your blood sugar.
- Carry glucose tablets or juice, and treat shakiness, sweating, confusion or a racing heart right away, because alcohol and hard exercise raise the risk.
- Expect glimepiride to work within days while pioglitazone builds slowly over several weeks, which is why dose changes come gradually.
- Expect a liver blood test before starting, and report dark urine, yellowing skin or eyes, or upper right belly pain right away.
FDA Boxed WarningThe FDA’s strongest safety alert. Read what it says about Glimepiride / Pioglitazone.
This medicine can cause or worsen heart failure. Pioglitazone, one of its two ingredients, can make your body hold extra fluid, which can strain the heart.
Watch for fast weight gain, shortness of breath, or swelling, especially after starting or raising the dose. If heart failure develops, your doctor may lower or stop the medicine. It is not recommended if you have symptoms of heart failure. It must not be started if you have moderate to severe heart failure (NYHA Class III or IV).
Patient Information Guide for Glimepiride / Pioglitazone
What It’s Used For
Glimepiride / Pioglitazone is a combination diabetes medicine taken by mouth as a tablet.
- Duetact and pioglitazone and glimepiride tablets are used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
- They suit people already taking a thiazolidinedione and a sulfonylurea, or those not controlled on one of them alone.
- They are not for type 1 diabetes or diabetic ketoacidosis.
How It Works
The tablet contains two medicines with different actions. Pioglitazone (a thiazolidinedione) is an insulin sensitizer. It lowers insulin resistance in muscle, fat, and the liver, so your body uses insulin better and the liver releases less sugar. It only works if your body still makes some insulin.
Glimepiride (a sulfonylurea) stimulates the pancreas beta cells to release more insulin.
Drug Class
Drug Class
- Sulfonylurea from glimepiride
- Peroxisome Proliferator-activated Receptor alpha Agonist from pioglitazone
- Peroxisome Proliferator-activated Receptor gamma Agonist from pioglitazone
- Thiazolidinedione from pioglitazone
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class. Glimepiride / Pioglitazone has two active ingredients, so each class says which one it comes from.
Drug Class
Established Pharmacologic Class (EPC)- Sulfonylurea from glimepiride
- Peroxisome Proliferator-activated Receptor alpha Agonist from pioglitazone
- Peroxisome Proliferator-activated Receptor gamma Agonist from pioglitazone
- Thiazolidinedione from pioglitazone
The main drug class the FDA gives it. It is the class named on the drug’s label.
How It Works
Mechanism of action (MoA)- Peroxisome Proliferator-activated Receptor alpha Agonists from pioglitazone
- Peroxisome Proliferator-activated Receptor gamma Agonists from pioglitazone
What it does at the smallest level, such as a receptor or enzyme it blocks or switches on.
What It Does in the Body
Physiologic effect (PE)None listed for Glimepiride / Pioglitazone in the FDA’s index.
From our Patient Information GuideThe tablet contains two medicines with different actions. Pioglitazone (a thiazolidinedione) is an insulin sensitizer. It lowers insulin resistance in muscle, fat, and the liver, so your body uses insulin better and the liver releases less sugar. It only works if your body still makes some insulin. Glimepiride (a sulfonylurea) stimulates the pancreas beta cells to release more insulin. Read How Glimepiride / Pioglitazone Works
A change it makes in how the body works.
Chemical Family
Chemical structure (CS)- Sulfonylurea Compounds from glimepiride
- Thiazolidinediones from pioglitazone
The chemical family it belongs to, by its structure.
Drug Family
WHO ATC classification- Combinations of oral blood glucose lowering drugs
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The classes are the FDA’s own words, from its index of drug labels, published in the National Library of Medicine’s RxClass. The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification. Reference only, not medical advice.
Dosage
This medicine is taken by mouth once a day with the first main meal. Your prescriber chooses the starting strength from your current diabetes treatment and adjusts it gradually based on response and tolerability.
- Liver blood tests are done before starting.
- If you switch from another sulfonylurea, you may be watched for low blood sugar for one to two weeks.
- If you take colesevelam, take this tablet at least 4 hours before it.
Follow your prescriber and pharmacy label, and ask your pharmacist what to do about a missed dose.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Type 2 diabetes (blood sugar control)
Starting dose, patients for whom a pioglitazone and glimepiride combination tablet is considered appropriate Starting dose 30 mg/2 mg or 30 mg/4 mg once a day Highest dose Pioglitazone 45 mg and glimepiride 8 mg a day
- 30 mg/2 mg or 30 mg/4 mg once daily with the first main meal, gradually titrated, as needed, after assessing adequacy of therapeutic response and tolerability
Adults whose blood sugar is not controlled on glimepiride alone · Starting dose Starting dose 30 mg/2 mg or 30 mg/4 mg once a day Highest dose Pioglitazone 45 mg and glimepiride 8 mg a day
- 30 mg/2 mg or 30 mg/4 mg once daily and gradually titrated, as needed, after assessing adequacy of therapeutic response and tolerability
Adults whose blood sugar is not controlled on pioglitazone alone · Starting dose Starting dose 30 mg/2 mg once a day Highest dose Pioglitazone 45 mg and glimepiride 8 mg a day
- 30 mg/2 mg once daily and gradually titrated, as needed, after assessing adequacy of therapeutic response and tolerability
Patients with systolic dysfunction
For adults
Highest dose Pioglitazone 45 mg and glimepiride 8 mg a day
- Lowest approved dose of Duetact, only after titration from 15 mg to 30 mg of pioglitazone has been safely tolerated
Good to know
Monitor for hypoglycemia and fluid retention
Other Doses
Adults switching from separate pioglitazone and glimepiride tablets · Starting dose Highest dose Pioglitazone 45 mg and glimepiride 8 mg a day
- Doses as close as possible to the dose of pioglitazone and glimepiride already being taken
Special Situations
Patients on a different sulfonylurea monotherapy or switching from pioglitazone plus a different sulfonylurea
30 mg/2 mg once daily and adjusted after assessing adequacy of therapeutic response; observe for hypoglycemia for one to two weeks
Potential overlapping drug effect
Side Effects
The most common side effects seen in studies include:
Common side effects
- Upper respiratory tract infection (cold-like symptoms)
- Swelling (edema), especially in the legs
- Weight gain
- Low blood sugar (hypoglycemia)
- Headache
- Accidental injury
- Urinary tract infection
- Diarrhea or nausea
When to get medical help
- Get help right away if you have rapid weight gain, shortness of breath, or swelling, which can be signs of heart failure.
- Call for emergency help if you have a serious allergic reaction, such as trouble breathing, swelling of the face or throat, or a severe skin reaction.
- Severe low blood sugar can cause confusion, passing out, or seizures and is an emergency.
- Call your doctor if you have unusual tiredness, loss of appetite, pain in the upper right belly, dark urine, or yellowing of the skin or eyes, which can signal liver problems.
- Report sudden vision changes or blurred vision, since swelling in the eye (macular edema) has been reported.
- Tell your doctor about any bone fractures, especially if you are a woman.
Warnings and Precautions
- Heart failure: This medicine can cause fluid retention and cause or worsen heart failure. Watch for rapid weight gain, shortness of breath, and swelling.
- Low blood sugar: Can be severe and can impair concentration and driving. Older adults and people with kidney, liver, adrenal, or pituitary problems are at higher risk.
- Liver effects: Liver failure has been reported, sometimes fatal. Report fatigue, poor appetite, upper right belly pain, dark urine, or yellow skin.
- Bladder cancer: May increase risk. Not for active bladder cancer.
- Fractures: More common in women.
- Allergic reactions: Serious ones have been reported with glimepiride.
- Hemolytic anemia: Possible, especially with G6PD deficiency.
- Eye swelling: Macular edema has been reported, so keep up with regular eye exams.
- Heart risk: Sulfonylureas may carry a possible increased risk of cardiovascular death.
Interactions
Many medicines can change how this tablet works, so share your full medicine list with your pharmacist.
- Gemfibrozil (strong CYP2C8 inhibitor): raises pioglitazone levels, so separate ingredients may be needed.
- Rifampin: can lower pioglitazone and glimepiride levels.
- Topiramate: may lower pioglitazone levels.
- Oral miconazole and fluconazole: can cause severe low blood sugar.
- Insulin and other diabetes drugs: higher risk of low blood sugar.
- Corticosteroids, thiazide diuretics, estrogens, birth control pills, and others: can raise blood sugar.
- Beta-blockers, clonidine, reserpine: may change blood sugar effects and mask low blood sugar signs.
- Alcohol: unpredictable effect on blood sugar.
- Colesevelam: lowers glimepiride absorption unless taken 4 hours later.
Interactions Listed in the FDA-Approved Label
From the Glimepiride / Pioglitazone prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
Strong CYP2C8 inhibitors For example: gemfibrozilWhat happensIncrease pioglitazone exposure approximately 3-fold.What to doMaximum pioglitazone dose is 15 mg daily; patients should switch to the individual components because the minimum pioglitazone dose in the tablet exceeds 15 mg.
-
CYP2C8 inducers For example: rifampinWhat happensMay decrease pioglitazone exposure.What to doChanges in diabetes treatment may be needed without exceeding 45 mg of pioglitazone daily.
-
What happensDecreases exposure of pioglitazone and its active metabolites.What to doMonitor for adequate glycemic control.
-
Drugs affecting glucose metabolismWhat happensMany medications can increase or reduce the glucose-lowering effect, causing hypoglycemia or worsening glycemic control.What to doDose adjustment and close monitoring of blood glucose may be needed.
-
Beta-blockers, clonidine, reserpineWhat happensMay potentiate or weaken the glucose-lowering effect; signs of hypoglycemia may be reduced or absent.
-
AlcoholWhat happensAcute and chronic intake may potentiate or weaken the glucose-lowering action unpredictably.
-
Miconazole (oral)What happensPotential interaction with sulfonylureas leading to severe hypoglycemia.
-
CYP2C9 inhibitors For example: fluconazoleWhat happensMay increase glimepiride concentrations, which may lead to hypoglycemia.
-
CYP2C9 inducers For example: rifampinWhat happensMay decrease glimepiride concentrations, which may lead to worsening glycemic control.
-
What happensReduces maximum plasma concentration and total exposure of glimepiride when coadministered.What to doAdminister at least four hours prior to colesevelam.
Read the label’s full interactions text
7 DRUG INTERACTIONS Strong CYP2C8 inhibitors (e.g., gemfibrozil) increase pioglitazone concentrations. Limit pioglitazone dose to 15 mg daily. CYP2C8 inducers (e.g., rifampin) may decrease pioglitazone concentrations. Topiramate may decrease pioglitazone concentrations. Certain medications may affect glucose metabolism, requiring pioglitazone and glimepiride tablet dose adjustment and close monitoring of blood glucose. Miconazole: Severe hypoglycemia can occur when pioglitazone and glimepiride tablets and oral miconazole are used concomitantly. CYP2C9 interactions: Inhibitors and inducers may affect glycemic control by altering glimepiride plasma concentrations. Colesevelam: Coadministration may reduce glimepiride absorption. Pioglitazone and glimepiride tablets should be administered at least 4 hours prior to colesevelam. 7.1 Strong CYP2C8 Inhibitors Pioglitazone An inhibitor of CYP2C8 (e.g., gemfibrozil) significantly increases the exposure (area under the serum concentration-time curve or AUC) and half-life (t ½ ) of pioglitazone. Therefore, the maximum recommended dose of pioglitazone is 15 mg daily if used in combination with gemfibrozil or other strong CYP2C8 inhibitors. Since the minimum dose of pioglitazone in pioglitazone and glimepiride tablets exceeds 15 mg, patients taking concomitant strong CYP2C8 inhibitors should switch to individual components of pioglitazone and glimepiride tablets, unless the prescribing health care provider determines that the benefit of pioglitazone and glimepiride tablets clearly outweighs the risk of increased pioglitazone exposure. 7.2 CYP2C8 Inducers Pioglitazone An inducer of CYP2C8 (e.g., rifampin) may significantly decrease the exposure (AUC) of pioglitazone.
Excerpted: the section continues on the label. Read the full Drug Interactions section on DailyMed →
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- Not for people starting with NYHA Class III or IV heart failure.
- Not for people allergic to pioglitazone, glimepiride, or sulfonamide medicines.
- Use caution with liver disease, edema, bladder cancer history, or G6PD deficiency.
- Older adults and people with kidney problems are at greater risk of low blood sugar.
- Not recommended for children.
- Pregnancy: discuss with your doctor. This medicine should be stopped at least two weeks before expected delivery because newborns can develop prolonged low blood sugar.
- Breastfeeding: discuss benefits and risks with your doctor.
- Premenopausal women should know unplanned pregnancy is possible.
Overdose
Too much glimepiride can cause severe low blood sugar, which is a medical emergency. Mild low blood sugar can be treated with oral glucose, while severe cases may need glucagon or intravenous glucose. Low blood sugar can come back after you seem to recover, so continued observation is needed.
How Your Body Processes It
Food does not change how much of either ingredient is absorbed, though it delays pioglitazone's peak and slightly raises glimepiride's peak. Pioglitazone reaches steady levels within about seven days, and both medicines are heavily bound to blood proteins. Both are broken down by the liver. Pioglitazone is processed mainly by CYP2C8 and glimepiride by CYP2C9.
Storage
Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) . Protect from moisture and humidity.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Glimepiride / Pioglitazone: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Glimepiride / Pioglitazone — the kind of thing our pharmacy team would talk through with you at the counter.
What is glimepiride / pioglitazone used for?
How should I take it?
Can this medicine cause weight gain or swelling?
What are the signs of low blood sugar and what should I do?
Can I drink alcohol while taking it?
Is it safe in pregnancy?
Is glimepiride / pioglitazone available over the counter?
When was glimepiride / pioglitazone first available?
Who makes glimepiride / pioglitazone?
What is the brand name of glimepiride / pioglitazone?
What is the generic name of Duetact?
What drug class is glimepiride / pioglitazone?
Is there a generic version of glimepiride / pioglitazone?
What strengths does glimepiride / pioglitazone come in?
How much does glimepiride / pioglitazone cost?
Where can I read the glimepiride / pioglitazone prescribing information (package insert)?
Is glimepiride / pioglitazone gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Glimepiride / Pioglitazone
Skip the scrolling. Ask in your own words and get an answer from Glimepiride / Pioglitazone’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Glimepiride / Pioglitazone’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Glimepiride / Pioglitazone on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Glimepiride / Pioglitazone Forms and Strengths (How It Comes)
Glimepiride / Pioglitazone comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Glimepiride / Pioglitazone inactive ingredients by manufacturer.
Tablet
How this form is used
- Duetact is used with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
- Pioglitazone and glimepiride tablets are used the same way when treatment with both ingredients is appropriate.
- Neither Duetact nor pioglitazone and glimepiride tablets are for type 1 diabetes or diabetic ketoacidosis.
- Duetact is taken by mouth once daily with the first main meal.
- Pioglitazone and glimepiride tablets are taken once daily with the first main meal.
- If you take colesevelam, Duetact should be taken at least 4 hours before it.
- Duetact and pioglitazone and glimepiride tablets come in more than one strength, so your prescriber picks the one for you.
Glimepiride / Pioglitazone on the U.S. Market: Products, Makers and Brands
How Glimepiride / Pioglitazone appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
2 companies list 4 Glimepiride / Pioglitazone product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2006. The one brand name in the directory today is Duetact; the rest are generics.
Also listed with the FDA, not a patient dose form: Unfinished tablet (4) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
How Widely Glimepiride / Pioglitazone Is Used (Medicaid Data)
How many Glimepiride / Pioglitazone prescriptions Medicaid paid for in Q1–Q4 2025, every brand, strength and form together. Medicaid is one program, so total U.S. use is higher.
How commonly is Glimepiride / Pioglitazone prescribed? Of the 1,682 medications we measure, Glimepiride / Pioglitazone ranks #1,362 by Medicaid prescriptions — more than 19% of them.
Utilization by Glimepiride / Pioglitazone product
Pick a strength and form to see its own numbers. Brand and generic versions are counted together.
glimepiride 4 MG / pioglitazone 30 MG Oral Tablet Most dispensed
1 of 7 listed NDCs had Medicaid claims. RxNorm 647239
glimepiride 2 MG / pioglitazone 30 MG Oral Tablet
1 of 7 listed NDCs had Medicaid claims. RxNorm 647237
Dollars are what Medicaid paid before the rebates drug makers send back, so its real cost is lower.
Source: Medicaid State Drug Utilization Data (CMS), all states. 2 of the 14 listed Glimepiride / Pioglitazone NDCs had Medicaid claims.
Compare Glimepiride / Pioglitazone Products
A representative set of FDA-listed product records for Glimepiride / Pioglitazone — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| PIOGLITAZONE HYDROCHLORIDE 30 mg/1; GLIMEPIRIDE 2 mg | Oral | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 30 mg/1; GLIMEPIRIDE 4 mg | Oral | Prasco Laboratories | NDA AUTHORIZED GENERIC | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 30 mg/1; GLIMEPIRIDE 2 mg | Oral | Takeda Pharmaceuticals America, Inc. | NDA | View NDC → |
| PIOGLITAZONE HYDROCHLORIDE 30 mg/1; GLIMEPIRIDE 4 mg | Oral | Takeda Pharmaceuticals America, Inc. | NDA | View NDC → |
Showing 4 of 4 products — FDA National Drug Code Directory. See every product, package size and price: browse all 4 Glimepiride / Pioglitazone NDCs →
Glimepiride / Pioglitazone Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Glimepiride / Pioglitazone — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Glimepiride / Pioglitazone in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Glimepiride / Pioglitazone FDA Approval History
How Glimepiride / Pioglitazone went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Glimepiride / Pioglitazone Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Glimepiride / Pioglitazone recalls since July 2021.
✅No Glimepiride / Pioglitazone recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Glimepiride / Pioglitazone in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one exact combination of ingredients (MIN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. A different combination is a different concept with its own page.
- Dose forms
- 1
- Strengths
- 2
- Forms in current FDA listings
- 1 of 1
RxCUI 647235 -
Dose form (SCDF) Oral TabletIn current FDA listings
RxCUI 647236Its 2 strengths (SCD)-
glimepiride 2 mg / pioglitazone 30 mg
RxCUI 647237 -
glimepiride 4 mg / pioglitazone 30 mg
RxCUI 647239
-
glimepiride 2 mg / pioglitazone 30 mg
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Glimepiride / Pioglitazone Supply and Shortage Status
Whether Glimepiride / Pioglitazone is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
What Glimepiride / Pioglitazone Costs Pharmacies (NADAC Benchmark)
What pharmacies pay to buy Glimepiride / Pioglitazone: the national average from CMS’s weekly NADAC survey, as of Nov 18, 2026. It is the pharmacy’s cost, not your price at the counter.
How the Pharmacy Price Has Changed
Pick a strength to see how its price has changed since Apr 2024.
For the generic PIOGLITAZONE HYDROCHLORIDE 30 mg/1; GLIMEPIRIDE 4 mg tablet, pharmacies paid an average of $9.95 per tablet as of Nov 18, 2026, down 12% from $11.35 a year earlier.
- What pharmacies pay now
- $9.95
- per tablet, as of Nov 18, 2026
- Last 4 weeks
- Down 3.6%
- from $10.32 on Oct 21, 2026
- Last 12 months
- Down 12%
- from $11.35 on Nov 19, 2025
- Lowest and highest since Apr 2024
- $7.79 to $11.45
- per tablet
See the numbers, month by month
| Month | Pharmacy price |
|---|---|
| Nov 2026 | $9.95 |
| Oct 2026 | $10.32 |
| Sep 2026 | $10.52 |
| Aug 2026 | $10.46 |
| Jul 2026 | $10.66 |
| Jun 2026 | $10.97 |
| May 2026 | $11.29 |
| Apr 2026 | $11.32 |
| Mar 2026 | $11.27 |
| Feb 2026 | $11.27 |
| Jan 2026 | $11.30 |
| Dec 2025 | $11.34 |
| Nov 2025 | $11.35 |
| Oct 2025 | $11.40 |
| Sep 2025 | $11.45 |
| Aug 2025 | $11.37 |
| Jul 2025 | $10.79 |
| Jun 2025 | $9.95 |
| May 2025 | $8.94 |
| Apr 2025 | $8.35 |
| Mar 2025 | $8.01 |
| Feb 2025 | $7.85 |
| Jan 2025 | $7.80 |
| Dec 2024 | $7.84 |
| Nov 2024 | $7.79 |
| Oct 2024 | $8.08 |
| Sep 2024 | $8.81 |
| Aug 2024 | $8.78 |
| Jul 2024 | $8.78 |
| Jun 2024 | $9.61 |
| May 2024 | $9.86 |
| Apr 2024 | $9.86 |
| Form | Strength | Version | What pharmacies pay | |
|---|---|---|---|---|
| Tablet · Oral | PIOGLITAZONE HYDROCHLORIDE 30 mg/1; GLIMEPIRIDE 2 mg | Generic | $9.60 per tablet | NDC details & price history |
| Tablet · Oral | PIOGLITAZONE HYDROCHLORIDE 30 mg/1; GLIMEPIRIDE 4 mg | Generic | $9.95 per tablet | NDC details & price history |
Source: CMS National Average Drug Acquisition Cost (NADAC). Each row spans the package sizes CMS priced; the generic and the brand are priced separately.
Glimepiride / Pioglitazone Brand Names
Glimepiride / Pioglitazone has one brand name on record: Duetact. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Glimepiride / Pioglitazone: Manufacturers and Labelers
2 companies list Glimepiride / Pioglitazone products with the FDA. By number of product records, the largest are Prasco Laboratories, Takeda Pharmaceuticals America, Inc.. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Glimepiride / Pioglitazone Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. Takeda Pharmaceuticals America, Inc. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →